Value
7.4/10data confidence 100%| Component | Sub-score |
|---|---|
| P/E | 7.3 |
| P/S | 8.9 |
| EV/EBITDA | 5.4 |
| Fwd P/E | 8.7 |
| PEG | 7.7 |
| Analyst target | 6.0 |
- ▸Forward P/E: 12.9x
- ▸PEG: 0.88
- ▸Attractively valued
CVSA · Why this verdict
Why Covista (CVSA) is rated SELL
Updated
Model-generated analysis — not investment advice. Not a registered investment advisor. Past performance does not guarantee future results.
Show full disclosure ▾Hide full disclosure ▴
About TrendMatrix. TrendMatrix is a publisher of general securities research and market commentary. We publish on a regular schedule. All content is the same for every subscriber in a tier — we do not provide personalized investment advice and we do not take into account any individual subscriber's financial situation, investment objectives, risk tolerance, tax situation, or holdings.
Not investment advice. TrendMatrix is not a registered investment adviser. Our content is for informational and educational purposes only. Consult your own licensed investment adviser, broker, or tax professional before making any investment decision.
Conflicts and positions. The TrendMatrix editorial team frequently holds personal long-term positions in securities discussed. We disclose positions held at the time of publication on each piece. We maintain a trading-window policy: we do not initiate or close positions in the same direction as a TrendMatrix publication within 24 hours before or 72 hours after publication.
No paid promotion. TrendMatrix does not accept payment from any issuer, broker, or third party in exchange for coverage of any security. Our sole compensation is subscription revenue.
No fiduciary duty. No fiduciary, advisory, or agency relationship is created between you and TrendMatrix by reading our content or subscribing to our service.
Performance. Past performance is not indicative of future results. Performance figures reflect the published model only and do not reflect any individual subscriber's actual results.
VerdictSELL
Overall score5.4/10
ConfidenceMEDIUM
MacroNEUTRAL
TrendMatrix Research · core thesis
Engine thesis — one sentence
Covista screens attractively valued at a forward P/E of 13.2 times and a PEG of 0.88, underpinned by four consecutive earnings beats averaging more than 11% above consensus; the chief offset is negative price momentum that has not cleared the minimum threshold, keeping the entry setup cautious despite sound fundamentals.
Falsifiable statement — pillar-level invalidators below. Engine-derived; not personalized advice.
Thesis pillars
| Pillar | Expectation | Trend |
|---|---|---|
Price momentum has stalled well below the acceptable threshold, with falling on-balance volume indicating distribution rather than accumulation — a near-term headwind that limits the attractiveness of the current entry even as fundamentals remain intact. Warnings | Over 12 months the stock recovers toward its near-term price target as momentum improves, validating that the weakness was temporary. | ↓Deteriorating |
| CounterThe stock remains above its 200-day moving average, meaning the weakness may be a pullback within a longer uptrend rather than a structural reversal. | ||
At a forward P/E of 13.2 times and a PEG of 0.88, the stock screens as attractively valued, offering a meaningful margin of safety and potential for multiple expansion if earnings momentum continues. Valuation breakdown | Forward P/E holds at or below 15 times as earnings grow into the valuation, and the stock outperforms sector peers on a 12-month total-return basis. | ↑Improving |
| CounterWeak organic growth limits the catalyst for re-rating; inexpensive stocks with minimal top-line momentum can remain cheap for extended periods. | ||
A Piotroski F-Score of 7 out of 9 combined with strong free-cash-flow quality signals a financially healthy business with limited near-term distress risk. Quality breakdown | The Piotroski F-Score remains at 7 or above for four consecutive quarters and free-cash-flow quality does not deteriorate materially. | →Stable |
| CounterA mid-range moat score means financial strength has not translated into durable pricing power; the quality profile is solid but not exceptional. | ||
The company has beaten consensus EPS estimates in each of the last four reported quarters, with average upside of roughly 11% above expectations — a pattern consistent with management consistently under-promising and over-delivering. Earnings | Average quarterly EPS surprise remains above 5% and the beat streak extends to six or more consecutive quarters over the next 12 months. | →Stable |
| CounterRevenue growth is near the bottom of the peer range, suggesting beats reflect modest consensus targets on a slow-growth business rather than genuine earnings acceleration. | ||
Price momentum has stalled well below the acceptable threshold, with falling on-balance volume indicating distribution rather than accumulation — a near-term headwind that limits the attractiveness of the current entry even as fundamentals remain intact.
↓DeterioratingWarnings
- Expectation
- Over 12 months the stock recovers toward its near-term price target as momentum improves, validating that the weakness was temporary.
CounterThe stock remains above its 200-day moving average, meaning the weakness may be a pullback within a longer uptrend rather than a structural reversal.
At a forward P/E of 13.2 times and a PEG of 0.88, the stock screens as attractively valued, offering a meaningful margin of safety and potential for multiple expansion if earnings momentum continues.
↑ImprovingValuation breakdown
- Expectation
- Forward P/E holds at or below 15 times as earnings grow into the valuation, and the stock outperforms sector peers on a 12-month total-return basis.
CounterWeak organic growth limits the catalyst for re-rating; inexpensive stocks with minimal top-line momentum can remain cheap for extended periods.
A Piotroski F-Score of 7 out of 9 combined with strong free-cash-flow quality signals a financially healthy business with limited near-term distress risk.
→StableQuality breakdown
- Expectation
- The Piotroski F-Score remains at 7 or above for four consecutive quarters and free-cash-flow quality does not deteriorate materially.
CounterA mid-range moat score means financial strength has not translated into durable pricing power; the quality profile is solid but not exceptional.
The company has beaten consensus EPS estimates in each of the last four reported quarters, with average upside of roughly 11% above expectations — a pattern consistent with management consistently under-promising and over-delivering.
→StableEarnings
- Expectation
- Average quarterly EPS surprise remains above 5% and the beat streak extends to six or more consecutive quarters over the next 12 months.
CounterRevenue growth is near the bottom of the peer range, suggesting beats reflect modest consensus targets on a slow-growth business rather than genuine earnings acceleration.
Per-dimension breakdown
Quality
6.4/10data confidence 100%| Component | Sub-score |
|---|---|
| ROE | 6.0 |
| ROA | 5.6 |
| Gross margin | 7.5 |
| Op margin | 7.6 |
| Net margin | 6.1 |
| Current ratio | 2.8 |
| FCF quality | 7.9 |
| Moat | 6.5 |
| Piotroski F | 7.8 |
- ▸Strong Piotroski F-Score: 7/9
Growth
1.8/10data confidence 67%| Component | Sub-score |
|---|---|
| Rev growth | 3.6 |
| EPS growth | 0.0 |
Momentum
3.7/10data confidence 100%| Component | Sub-score |
|---|---|
| RSI | 5.5 |
| MACD | 0.0 |
| OBV | 10.0 |
| MA position | 3.0 |
| Volume | 0.1 |
- ▸Volume accumulation (rising OBV)
- ▸Above 200-MA but MA slope flat
Sentiment
6.2/10data confidence 100%| Component | Sub-score |
|---|---|
| Analyst rating | 5.0 |
| Price target | 8.8 |
| erm sentiment | 5.0 |
- ▸Analyst upside: 34%
Insider
5.5/10data confidence 100%| Component | Sub-score |
|---|---|
| materiality | 3.0 |
| insider conviction | 2.0 |
| holder change | 10.0 |
| notable moves | 7.0 |
- ▸Notable insider selling — $6,914,560 (0.177% of mkt cap)
- ▸Institutions accumulating
Peer rank
4.6/10data confidence 80%| Component | Sub-score |
|---|---|
| value rank | 4.1 |
| quality rank | 6.9 |
| growth rank | 3.5 |
Technical
7.2/10data confidence 100%| Component | Sub-score |
|---|---|
| bollinger | 8.4 |
| support resistance | 8.4 |
| 52w position | 4.9 |
Risk (lower is worse)
5.9/10data confidence 100%| Component | Sub-score |
|---|---|
| short interest | 6.5 |
| days to cover | 5.8 |
| volatility | 0.0 |
| beta | 9.3 |
| debt equity | 7.8 |
Catalyst
7.0/10data confidence 100%| Component | Sub-score |
|---|---|
| erm | 5.0 |
| earnings history | 10.0 |
| earnings timing | 5.0 |
| surprise avg | 8.2 |
- ▸Perfect beat streak: 4Q
How the verdict was assembled
Engine trigger
Multiple concerning factors. Consider reducing position.
Engine technical detail
verdict_path:
L4:PATH_F_SELLPassed (6)
- INSIDER:OK
- 8K:CLEAN
- NEWS_EVENTS:NONE_RECENT
- EARNINGS_PROXIMITY:16d clear
- SEMI_CYCLE_PEAK:CLEAR
- MATERIALS_CYCLE_PEAK:CLEAR
Failed (2)
- MOMENTUM:3.7<4.5
- ASYMMETRY:1.4<1.5@spot
Warning (0)
none
Reward-to-Risk
1.39
Upside
+13.9%
Downside
10.0%
Sizing output
AVOID
Setup— — No clear chart pattern; technical signals are mixed
EdgeCatalyst-Driven — Earnings in 16d with 4/4 beat streak
SuitabilityAggressive — MCap $3.9B<$5B
Investment implication
The F-path SELL output reflects an overall score of 5.4 below the 5.6 soft trigger — multiple weakening dimensions accumulated rather than a single hard-floor breach. The strongest dimension ( Value at 7.4) was not enough to lift the adjusted overall above the threshold. Co-occurring failed gates ( MOMENTUM:3.7<4.5, ASYMMETRY:1.4<1.5@spot) reinforce the read. Current asymmetry R:R is 1.39 — supplementary context, not the trigger for this path.
The strongest dimensions are Value at 7.4, Technical at 7.2, and Catalyst at 7.0; the weakest are Growth at 1.8, Momentum at 3.7, and Peer rank at 4.6. The V9 engine flagged 2 failed gates, producing an asymmetric reward-to-risk of 1.39 and an engine sizing output of AVOID.
What would invalidate the thesis
Falsifying conditions — when triggered, the corresponding pillar's thesis is invalidated.
- P1Consistent Earnings Beat Streak
Trip ifEPS surprise falls below 0% for 2 consecutive quarters.
- P2Attractive Forward Valuation Low Peg
Trip ifForward P/E expands above 20x from the current 13.2x for 2 consecutive quarters.
- P3Solid Piotroski Financial Health
Trip ifPiotroski F-Score falls below 5 out of 9 in any single quarter.
- P4Negative Momentum Near Term Headwind
Trip ifPrice closes above $132.81 (near-term price target) and holds for 2 consecutive weeks, confirming the momentum headwind has resolved.